Brief: Context Therapeutics Reports Third Quarter 2021 Operating And Financial Results
02/12/2021 21:05
Dec 2 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS® REPORTS THIRD QUARTER 2021 OPERATING
AND
FINANCIAL RESULTS
* CONTEXT THERAPEUTICS - EXPECTS CASH & CASH EQUIVALENTS
WILL BE
SUFFICIENT TO FUND ITS OPERATIONS INTO 2024
* CONTEXT THERAPEUTICS - QTRLY LOSS PER SHARE $4.00)
Source text for Eikon: ID:nGNX6WWTjY
Further company coverage: CNTX.O
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202